KHALINA HERRAND: Open Payments
NPI 1104414853 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 6 payments from 6 companies in 2025. Trend: 2023 $599 · 2024 $392 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $89 |
| Celgene Corporation | 1 | $30 |
| Legend Biotech USA Inc. | 1 | $24 |
| ViiV Healthcare Company | 1 | $24 |
| GENZYME CORPORATION | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: CARVYKTI, REBLOZYL, APRETUDE, SARCLISA, NINLARO.
Industry payments across NY — which companies pay providers there.
